Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1864-6433
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 ; volume:36 ; number:4 ; day:19 ; month:1 ; year:2022 ; pages:373-383 ; date:4.2022
Annals of nuclear medicine ; 36, Heft 4 (19.1.2022), 373-383, 4.2022
- Urheber
-
Bauckneht, Matteo
Lai, Rita
D’Amico, Francesca
Miceli, Alberto
Donegani, Maria Isabella
Campi, Cristina
Schenone, Daniela
Raffa, Stefano
Chiola, Silvia
Lanfranchi, Francesco
Rebuzzi, Sara Elena
Zanardi, Elisa
Cremante, Malvina
Marini, Cecilia
Fornarini, Giuseppe
Morbelli, Silvia
Piana, Michele
Sambuceti, Gianmario
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12149-022-01716-w
- URN
-
urn:nbn:de:101:1-2022061122102571097504
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bauckneht, Matteo
- Lai, Rita
- D’Amico, Francesca
- Miceli, Alberto
- Donegani, Maria Isabella
- Campi, Cristina
- Schenone, Daniela
- Raffa, Stefano
- Chiola, Silvia
- Lanfranchi, Francesco
- Rebuzzi, Sara Elena
- Zanardi, Elisa
- Cremante, Malvina
- Marini, Cecilia
- Fornarini, Giuseppe
- Morbelli, Silvia
- Piana, Michele
- Sambuceti, Gianmario
- SpringerLink (Online service)
Ähnliche Objekte (12)
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Targeting molecular resistance in castration-resistant prostate cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Targeting molecular resistance in castration-resistant prostate cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Targeting molecular resistance in castration-resistant prostate cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends